Keyword Connections

non-small cell lung cancer

Journals

23

1 Scientific reports

2 International journal of pharmaceutics

3 Molecular diversity

4 medical hypotheses

5 Advances in therapy

6 tumori

7 lung cancer (amsterdam, netherlands)

8 Journal of cancer research and clinical oncology

9 Clinical drug investigation

10 journal of materials chemistry b

11 Aging

12 sichuan da xue xue bao yi xue ban = journal of sichuan university medical science edition

13 oncoimmunology

14 the journal of sports medicine and physical fitness

15 journal of thoracic oncology : official publication of the international association for the study of lung cancer

16 journal of cognitive neuroscience

17 Pulmonary pharmacology & therapeutics

18 reproduction, fertility, and development

19 the lancet oncology

20 international journal of clinical and experimental pathology

21 clinical nephrology

22 Targeted oncology

23 Skin health and disease

Research Groups

0

No Research Group Connected

Bibliographies

152

1 Tc-vinorelbine tartrate loaded spherulites: Lung disposition study in Sprague-Dawley rats by gamma scintigraphy.

2 Culture conditions affect Ca release in artificially activated mouse and human oocytes.

3 Impact of Specimen Characteristics on PD-L1 Testing in Non-Small Cell Lung Cancer: Validation of the IASLC PD-L1 Testing Guidelines.

4 Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis.

5 Long non-coding RNA TUG1 enhances chemosensitivity in non-small cell lung cancer by impairing microRNA-221-dependent PTEN inhibition.

6 Expression and clinical significance of PD-L1 and c-Myc in non-small cell lung cancer.

7 Effects of gefitinib treatment on cellular uptake of extracellular vesicles in EGFR-mutant non-small cell lung cancer cells.

8 pH-Responsive polyelectrolyte coated gadolinium oxide-doped mesoporous silica nanoparticles (GdO@MSNs) for synergistic drug delivery and magnetic resonance imaging enhancement.

9 Thyroid metastasis from non-small cell lung cancer.

10 Can ferric citrate lead to iron overload in peritoneal dialysis patients? .

11 Tracking the Effects of Top-Down Attention on Word Discrimination Using Frequency-tagged Neuromagnetic Responses.

12 Unraveling the Relation between Electroencephalogram Correlates of Attentional Orienting and Sound Localization Performance: A Diffusion Model Approach.

13 Strategies for improving the pedaling technique.

14 Hsa_circ_0102533 serves as a blood-based biomarker for non-small-cell lung cancer diagnosis and regulates apoptosis in vitro.

15 Molecular testing for advanced non-small cell lung cancer in Malaysia: Consensus statement from the College of Pathologists, Academy of Medicine Malaysia, the Malaysian Thoracic Society, and the Malaysian Oncological Society.

16 Pharmacophore-based designing of putative ROS-1 targeting agents for NSCLC.

17 [Effect of Silencing on Proliferation and Migration of H322 Cells and Its Mechanism].

18 Covid-19 and lung cancer: A greater fatality rate?

19 Fighting against frailty and sarcopenia - As well as COVID-19?

20 The use of aspirated consonants during speech may increase the transmission of COVID-19.

21 Oral cancer and periodontal disease increase the risk of COVID 19? A mechanism mediated through furin and cathepsin overexpression.

22 efficacy and safety of cox-2 inhibitors for advanced non-small-cell lung cancer with chemotherapy: a meta-analysis

23 effect of deep pressure input on parasympathetic system in patients with wisdom tooth surgery

24 new prognostic biomarkers and therapeutic effect of bevacizumab for patients with non-small-cell lung cancer

25 avastin in clinical chemotherapy of malignant tumors

26 benefit of a second opinion for lung cancer: no metastasis to the kidney but a synchronous primary renal neoplasm

27 role of fdg-pet scans in staging, response assessment, and follow-up care for non-small cell lung cancer

28 alkaline phosphatase flare phenomenon following epidermal growth factor receptor-tyrosine kinase inhibitor treatment of non-small cell lung cancer: report of a case and case review

29 stats family expression in non-small cell lung cancer tissue and their potential target genes

30 the efficacy and safety of nivolumab in previously treated advanced non-small-cell lung cancer: a meta-analysis of prospective clinical trials

31 chemotherapy in advanced non-small cell lung cancer: present and future

32 avaliação económica do erlotinib, docetaxel, pemetrexedo e tratamento de suporte no tratamento de segunda ou terceira linhas de doentes com cancro do pulmão de não pequenas células an economic analysis of erlotinib, docetaxel, pemetrexed and best supportive care as second or third line treatment of non-small cell lung cancer

33 the expression of aplysia ras homolog i (arhi) and its inhibitory effect on cell biological behavior in esophageal squamous cell carcinoma

34 pembrolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectives

35 Synergies of Targeting Tumor Angiogenesis and Immune Checkpoints in Non-Small Cell Lung Cancer and Renal Cell Cancer: From Basic Concepts to Clinical Reality

36 Current and Emerging Treatment Options for Patients with Metastatic EGFR-Mutated Non-small Cell Lung Cancer After Progression on Osimertinib and Platinum-Based Chemotherapy: A Podcast Discussion.

37 The long-term safety of topical corticosteroids in atopic dermatitis: A systematic review.

38 The impact of different distractions on outdoor visual search and object memory.

39 Acthar Gel Treatment for Patients with Autoimmune and Inflammatory Diseases: An Historical Perspective and Characterization of Clinical Evidence.

40 EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast.

41 Downregulation of TCEAL7 expression induces CCND1 expression in non-small cell lung cancer.

42 Automated AJCC (7th edition) staging of non-small cell lung cancer (NSCLC) using deep convolutional neural network (CNN) and recurrent neural network (RNN).

43 Afatinib for the treatment of metastatic non-small cell lung cancer

44 Afatinib for the treatment of metastatic non-small cell lung cancer

45 Afatinib for the treatment of metastatic non-small cell lung cancer

46 Analysis of Prognostic Factors in 541 Female Patients with Advanced Non-small Cell Lung Cancer

47 Treatment of metastatic non-small cell lung cancer: 2018 guidelines of the Italian Association of Medical Oncology (AIOM).

48 Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors.

49 Retraction notice to “miR-543 is up-regulated in gefitinib-resistant non-small cell lung cancer and promotes cell proliferation and invasion via phosphatase and tensin homolog” (Biochemical and Biophysical Research Communications (2016) 480(3) (369–374), (S0006291X16317338), (10.1016/j.bbrc.2016.10.055))

50 Retraction notice to “The miR-599 promotes non-small cell lung cancer cell invasion via SATB2” (Biochemical and Biophysical Research Communications (2017) 485(1) (35–40), (S0006291X17302668), (10.1016/j.bbrc.2017.02.005))

51 Correction: Artocarpin, an isoprenyl flavonoid, induces p53-dependent or independent apoptosis via ROS-mediated MAPKs and Akt activation in non-small cell lung cancer cells.

52 [Effects of Interference with UCA1 and Inhibition of miR-185-5p on Activation, Autophagy and Survival of β-Catenin Pathway in Non-small Cell Lung Cancer].

53 The effect of socioeconomic status on treatment and mortality in non-small cell lung cancer patients.

54 Treatment of Skin Reaction Induced by Nivolumab Combined with Radiotherapy in Non-small Cell Lung Cancer: A Case Report.

55 Joint Serum Tumor Markers Serve as survival predictive model of Erlotinib in the treatment of recurrent Non-small Cell Lung Cancer

56 Non-invasive classification of non-small cell lung cancer: a comparison between random forest models utilising radiomic and semantic features.

57 Nivolumab for advanced non-small cell lung cancer patients with mild idiopathic interstitial pneumonia: A multicenter, open-label single-arm phase II trial

58 Inclusion of Incidental Radiation Dose to the Cardiac Atria and Ventricles Does Not Improve the Prediction of Radiation Pneumonitis in Advanced-Stage Non-Small Cell Lung Cancer Patients Treated With Intensity Modulated Radiation Therapy.

59 Roles of PI3K/Akt and c-Jun signaling pathways in human papillomavirus type 16 oncoprotein-induced HIF-1α, VEGF, and IL-8 expression and in vitro angiogenesis in non-small cell lung cancer cells.

60 A prospective observational study of on-treatment plasma homocysteine levels as a biomarker of toxicity, depression and vitamin supplementation lead-in time pre pemetrexed, in patients with non-small cell lung cancer and malignant mesothelioma.

61 Histone Deacetylase Inhibitors as a Novel Targeted Therapy Against Non-small Cell Lung Cancer: Where Are We Now and What Should We Expect?

62 Independent prognostic value of ultra-sensitive quantification of tumor pre-treatment T790M subclones in EGFR mutated non-small cell lung cancer (NSCLC) treated by first/second generation TKI, depends on variant allele frequency (VAF): Results of the French cooperative thoracic intergroup (IFCT) biomarkers France project.

63 Kanglaite injection plus platinum-based chemotherapy for stage III/IV non-small cell lung cancer: A meta-analysis of 27 RCTs.

64 Fibroblasts and alectinib switch the evolutionary games played by non-small cell lung cancer.

65 Concordance Between Rapid On-Site Evaluation and Final Cytologic Diagnosis in Patients Undergoing Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Non-Small Cell Lung Cancer Staging

66 Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with “curative” intent

67 LncRNA SNHG16 promotes non-small cell lung cancer development through regulating EphA2 expression by sponging miR-520a-3p.

68 Nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2) in non-small cell lung cancer.

69 Screening Key Genes Associated with the Development and Progression of Non-small Cell Lung Cancer Based on Gene-enrichment Analysis and Meta-analysis

70 Asian Thoracic Oncology Research Group expert consensus statement on optimal management of stage III non-small cell lung cancer.

71 The Relative Importance of Clinical and Socio-Demographic Variables in Prognostic Prediction in Non-Small Cell Lung Cancer: A Variable Importance Approach.

72 A 5-Gene Signature Is Closely Related to Tumor Immune Microenvironment and Predicts the Prognosis of Patients with Non-Small Cell Lung Cancer.

73 Down-regulation of tissue factor inhibits invasion and metastasis of non-small cell lung cancer.

74 Does advanced lung inflammation index (ALI) have prognostic significance in metastatic non-small cell lung cancer?

75 Impact of a Non-small Cell Lung Cancer Educational Program for Interdisciplinary Teams.

76 Open-label, multicenter, randomized phase II study on docetaxel plus bevacizumab or pemetrexed plus bevacizumab for treatment of elderly (aged ≥75 years) patients with previously untreated advanced non-squamous non-small cell lung cancer: TORG1323.

77 surgical treatment for non-small cell lung cancer in patients on hemodialysis due to chronic kidney disease: clinical outcome and intermediate-term results

78 over-expression of chromatin assembly factor 1 subunit a (chaf1a) facilitates cell proliferation in non-small cell lung cancer (nsclc)

79 mechanism of c-met in non-small cell lung cancer and its treatment and testing

80 overexpression of progerin results in impaired proliferation and invasion of non-small cell lung cancer cells

81 mutational analysis of hogg1 gene promoter in patients with non-small cell lung cancer

82 the changes of the first-line chemotherapy on advanced non-small cell lung cancer

83 significances of ret fusion gene in non-small cell lung cancer

84 up-regulation of fstl3, regulated by lncrna dscam-as1/mir-122-5p axis, promotes proliferation and migration of non-small cell lung cancer cells

85 surgical treatment for non-small cell lung cancer patients with synchronous solitary brain metastasis

86 impact of chemotherapy on symptom profile, oxidant-antioxidant balance and nutritional status in non-small cell lung cancer

87 numb chin syndrome as a manifestation of non-small cell lung cancer

88 a pilot study (swog s0429) of weekly cetuximab and chest radiotherapy for poor-risk stage iii non-small cell lung cancer

89 analysis of the factors associated with abnormal coagulation and prognosis in patients with non-small cell lung cancer

90 editorial: update on the treatment of metastatic non-small cell lung cancer (nsclc) in new era of personalised medicine

91 clinical observation of erlotnib in the treatment of non-small cell lung cancer with multimetastases in elderly patients

92 relationship between bim gene polymorphism and therapeutic efficacy in the  retreatment of advanced non-small cell lung cancer with tyrosine kinase inhibitor

93 risk factors for severe diarrhea with an afatinib treatment of non-small cell lung cancer: a pooled analysis of clinical trials

94 dabrafenib in combination with trametinib in the treatment of patients with braf v600-positive advanced or metastatic non-small cell lung cancer: clinical evidence and experience

95 relationship between the expression of prdm14 in non-small cell lung cancer and the clinicopathologic characteristics

96 pulmonary sarcoidosis activation following neoadjuvant pembrolizumab plus chemotherapy combination therapy in a patient with non-small cell lung cancer: a case report

97 analysis of subclassification by size and survival-associated factors of stageⅠnon-small cell lung cancer

98 clinicopathological significance of fascin-1 expression in patients with non-small cell lung cancer

99 effect of bufalin on proliferation and apoptosis of human non-small cell lung cancer a549 cell

100 detecção de micrometástases em câncer de pulmão não-pequenas células estádio pn0: um método alternativo combinando imunohistoquímica e análise em microsséries detection of micrometastases in pn0 non-small cell lung cancer: an alternative method combining tissue microarray and immunohistochemistry

101 clinical research of perioperative serum vegf and mmp-9 levels in patients with non-small cell lung cancer